112 related articles for article (PubMed ID: 3550065)
21. Bromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effects.
Nishimura K; Matsumiya K; Tsuboniwa N; Yamanaka M; Koga M; Miura H; Tsujimura A; Uchida K; Kondoh N; Kitamura M; Okuyama A
Arch Androl; 1999; 43(3):207-13. PubMed ID: 10624504
[TBL] [Abstract][Full Text] [Related]
22. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine control of gonadotropin secretion.
Porter JC; Nansel DD; Gudelsky GA; Foreman MM; Pilotte NS; Parker CR; Burrows GH; Bates GW; Madden JD
Fed Proc; 1980 Sep; 39(11):2896-901. PubMed ID: 6773815
[TBL] [Abstract][Full Text] [Related]
24. Pituitary responsiveness to luteinizing-hormone-releasing hormone in different reproductive disorders. A review.
Vasquez JM; Greenblatt RB
J Reprod Med; 1985 Aug; 30(8):591-600. PubMed ID: 3930718
[TBL] [Abstract][Full Text] [Related]
25. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
Rea N; Bove F; Gentile A; Parmeggiani U
Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
[TBL] [Abstract][Full Text] [Related]
26. [Variations of the plasma levels of gonadotrophins (FSH and LH) and of its response to stimulation with gonadotrophin releasing hormone (GnRH) with different plasma levels of prolactin (PRL) in women with the syndrome of galactorrhea-amenorrhea (author's transl)].
Salmerón de Diego J; Alonso Rodríguez C; Santos Reyero M; Salazar Orlando A; Palacios Mateos JM
Med Clin (Barc); 1981 Feb; 76(4):164-8. PubMed ID: 6782394
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
[TBL] [Abstract][Full Text] [Related]
28. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
Parra A; Crespo G; Coria I; Espinosa de los Monteros A
Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
[TBL] [Abstract][Full Text] [Related]
29. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
Lamberts SW; Docter R; De Jong FH; Birkenhäger JC; Kwa HG
Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383
[TBL] [Abstract][Full Text] [Related]
30. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
[TBL] [Abstract][Full Text] [Related]
31. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Seppälä M; Unnérus HA; Hirvonen E; Ranta T
J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
[TBL] [Abstract][Full Text] [Related]
32. Bromocriptine induced pregnancy in two cases of euprolactinemic hypothalamic amenorrhea.
Nencioni T; Miragoli A; Dorato F; Polvani F
J Endocrinol Invest; 1978 Jan; 1(1):65-7. PubMed ID: 114566
[TBL] [Abstract][Full Text] [Related]
33. Unusual prolactin response to luteinizing hormone-releasing hormone in some anovulatory women.
Giampietro O; Moggi G; Chisci R; Coluccia A; Luche AD; Simonini N; Brunori I
J Clin Endocrinol Metab; 1979 Jul; 49(1):141-3. PubMed ID: 376544
[TBL] [Abstract][Full Text] [Related]
34. Further acquisitions on gonadal function in bromocriptine treated hyperprolactinemic male patients.
Zini D; Carani C; Baldini A; Cavicchioli C; Piccinini D; Marrama P
Pharmacol Res Commun; 1986 Jul; 18(7):601-9. PubMed ID: 3532137
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
[TBL] [Abstract][Full Text] [Related]
36. Studies on the prolactin-releasing capacity of luteinizing hormone releasing hormone in male subjects.
Gooren LJ; Harmsen-Louman W; van Bergeyk L; van Kessel H
Exp Clin Endocrinol; 1985 Dec; 86(3):300-4. PubMed ID: 3912199
[TBL] [Abstract][Full Text] [Related]
37. PRL action on E2 ovarian secretion.
Polatti F; Nava C; Brambilla A; Zara C
Clin Exp Obstet Gynecol; 1982; 9(3):160-4. PubMed ID: 6819897
[TBL] [Abstract][Full Text] [Related]
38. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
Smith S
J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
[TBL] [Abstract][Full Text] [Related]
39. Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.
Genazzani AD; Petraglia F; Benatti R; Montanini V; Algeri I; Volpe A; Genazzani AR
J Clin Endocrinol Metab; 1991 Jun; 72(6):1220-5. PubMed ID: 2026744
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
